Stem-cell transplantation for high-risk breast cancer
Article Abstract:
The time to relapse may be a better method for evaluating breast cancer treatments than overall survival rates. Two studies published in 2003 on the use of high-dose chemotherapy and blood stem cell transplants for advanced breast cancer came to different conclusions. One found no difference in overall survival rates when compared to traditional chemotherapy and the other found that this treatment increased the time to relapse.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer
Article Abstract:
High-dose chemotherapy and a blood stem cell transplant may benefit some women with breast cancer that has spread to four or more lymph nodes, according to a study of 885 women. Women with cancer in four or more lymph nodes have the highest rates of relapse after traditional chemotherapy. Women who receive high-dose chemotherapy also receive a blood stem cell transplant because the chemotherapy damages their immune system.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
Article Abstract:
The efficacy of mammographic and MRI screening for breast cancer in women with a family history of the disease or a genetic predisposition to breast cancer is compared in this study. The study shows that the screening program used, especially MRI screening, can detect breast cancer at an early stage in women at risk for breast cancer.
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Localisation of vitronectin receptor immunoreactivity and tartrate resistant acid phosphatase activity in synovium from patients with inflammatory or degenerative arthritis
- Abstracts: Inflammation and cancer. Mast cells in autoimmune disease. eLixiRs for restraining inflammation
- Abstracts: Postmenopausal hormones -- therapy for symptoms only. From presumed benefit to potential harm -- hormone therapy and heart disease
- Abstracts: Lung transplantation for lymphangioleiomyomatosis. Interleukin-1-receptor antagonist in type 2 diabetes mellitus
- Abstracts: The many faces of celiac disease. The prevalence of occult gastrointestinal bleeding in celiac sprue. Celiac disease -- the villain unmasked?